Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

Background Patient-reported outcomes are increasingly used in the management of patients with multiple sclerosis to understand the patient's perspective of disease and treatment. These measures provide insights into important factors including treatment satisfaction, physical and psychological...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis journal - experimental, translational and clinical Jg. 8; H. 4; S. 20552173221135888
Hauptverfasser:	Wray, Sibyl, Jacques, Francois, Miller, Tamara A, Nicholas, Jacqueline A, Arroyo, Rafael, Travis, Lori, Khatri, Bhupendra, Chirieac, Magdalena, Gandhi, Roopali, Roesch, Nora, Rodrigues, Amelie, Melas-Melt, Lydie, Rawlings, Andreea M, Hunter, Samuel F
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London, England SAGE Publications 01.10.2022 Sage Publications Ltd
Schlagworte:	Monoclonal antibodies Multiple sclerosis Original Patients disease-modifying therapies Alemtuzumab quality of life multiple sclerosis
ISSN:	2055-2173, 2055-2173
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!